Argan S.A. ARLLF OTC · Real estate · France
$77.56 +0.00% +$0.00
Summary
78 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 32% a year over the last 3 years.
- Out of every 100 EUR of revenue, 102 EUR is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share swing sharply from year to year.
- For every 100 EUR of bills due within a year it has 52 EUR of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.8 EUR for 1 EUR of yearly profit. Over the last five years it was 9.2 EUR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 8.3% a year. For the next fiscal year analysts expect revenue to fall by 2.3%. Earnings per share grew by 32% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 14 EUR
- Sales and administration 8.9 EUR
- Taxes and other -26 EUR
- Net profit 102 EUR
Net profit, industry median (Real Estate - Development) 14 EUR
Out of every 100 EUR of revenue, 102 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 12.1 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 5.18%
- Paid out of profit
- 35%
- Raised in a row
- 1 year
You receive $4.02 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.